Kerstin Albertsson Wikland, Centrum för pediatrisk tillväxtforskning. Barnmedicin. Växthuset

Basuppgifter

Arbete

CV

Doctoral Thesis (1)

1. Effects of Growth Hormone on Protein Synthesis. An Experimental Study in the Diaphragm of Young Rats.
   Albertsson Wikland K.
   Göteborg: Göteborgs Universitet; 1979. [Source: User]

Article - Review (17)

1. Child health, developmental plasticity, and epigenetic programming.
   Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel J-C, Boileau P, Le Bouc Y, Deal C L, Lillycrop K, Scharfmann R, Sheppard A, Skinner M, Szyf M, Waterland R A, Waxman D J, Whitelaw E, Ong K, Albertsson-Wikland K.
   Endocr Rev. 2011:32(2):159-224.[Source: PubMed®]
   [Links: PMID: 20971919 | DOI länk]
2. Evo-devo of infantile and childhood growth.
   Hochberg Ze'ev, Albertsson-Wikland Kerstin.
   Pediatr Res. 2008:64(1):2-7.[Source: PubMed®]
   [Links: PMID: 18652011]
3. Pubertal growth assessment.
   Karlberg Johan, Kwan Chi-Wai, Gelander Lars, Albertsson-Wikland Kerstin.
   Horm Res. 2003:60(Suppl 1):27-35.[Source: PubMed®]
   [Links: PMID: 12955015 | DOI länk]
4. Management of puberty in constitutional delay of growth and puberty.
   De Luca F, Argente J, Cavallo L, Crowne E, Delemarre-Van de Waal H A, De Sanctis C, Di Maio S, Norjavaara E, Oostdijk W, Severi F, Tonini G, Trifirò G, Voorhoeve P G, Wu F;
   International Workshop on Management of Puberty for Optimum Auxological Results.
   J Pediatr Endocrinol Metab. 2001:14:953-7.[Source: PubMed®]
   [Links: PMID: 11529401]
5. Multiple pituitary hormone deficiency: management of puberty for optimal auxological results.
   Stanhope R, De Luca F, Delemarre-Van de Waal H A, Liotta A, Norjavaara E, Salvatoni A, Wu F;
   International Workshop on Management of Puberty for Optimum Auxological Results.
   J Pediatr Endocrinol Metab. 2001:14:1009-14.[Source: PubMed®]
   [Links: PMID: 11529397]
6. Recommendations for the diagnosis and management of Turner syndrome.
   Saenger P, Wikland K A, Conway G S, Davenport M, Gravholt C H, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino A M, Ranke M B, Rosenfeld R, Silberbach M;
   Fifth International Symposium on Turner Syndrome.
   J Clin Endocrinol Metab. 2001:86(7):3061-9.[Source: PubMed®]
   [Links: PMID: 11443168]
7. High prevalence of celiac disease in Turner's syndrome.
   Ivarsson S-A, Carlsson A, Bredberg A, J Alm, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Kriström B, Marcus C, Nilsson K, Tuvemo T, Westphal O, Albertsson-Wikland K.
   Review Series Pediatrics 2001:2(01)[Source: User]
8. Should we treat children with idiopathic short stature?
   Kelnar C J, Albertsson-Wikland K, Hintz R L, Ranke M B, Rosenfeld R G.
   Horm Res. 1999:52(3):150-7.[Source: PubMed®]
   [Links: PMID: 10725780]
9. Postnatal growth of children born small for gestational age.
   Albertsson-Wikland K, Karlberg J.
   Acta Paediatr Suppl 1997:423:193-5.[Source: PubMed®]
   [Links: PMID: 9401571]
10. Born small for gestational age: consequences for growth.
    Karlberg J, Albertsson-Wikland K, Baber F M, Low L C, Yeung C Y.
    Acta Paediatr Suppl 1996:417:8-13; discussion 14.[Source: PubMed®]
    [Links: PMID: 9055902]
11. New concepts emerging from analysis of population data.
    Karlberg J, Albertsson-Wikland Kerstin.
    Asia Pacific Paediatr Endocrinol 1996:13-9.[Source: User]
12. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited.
    Rosenfeld R G, Albertsson-Wikland K, Cassorla F, Frasier S D, Hasegawa Y, Hintz R L, Lafranchi S, Lippe B, Loriaux L, Melmed S.
    J Clin Endocrinol Metab. 1995:80(5):1532-40.[Source: PubMed®]
    [Links: PMID: 7538145]
13. Quantification and clinical relevance of serum insulin-like growth factors and insulin-like growth factor binding proteins.
    Rosenfeld R, Albertsson-Wikland Kerstin.
    Endocrinol Metab 1995:2([Suppl. B]):113-5.[Source: User]
14. Recommendations for Diagnosis, Treatment, and Management of Individuals with Turner Syndrome.
    Albertsson-Wikland Kerstin, Asch R, Cara J, Conte F, Hall J, Lippe B, McCauley E, Nagel T, Neely E, Page D, Ranke M, Rodriguez-Rigau L, Rosenfeld R, Saenger P, Tesch LG, Watkins J, Wilson M.
    Endocrinologist 1994:351-8.[Source: User]
15. Distinctions between short- and long-term human growth studies.
    Karlberg J, Gelander L, Albertsson-Wikland K.
    Acta Paediatr. 1993:82(8):631-4.[Source: PubMed®]
    [Links: PMID: 8374209]
16. Conclusions: a consensus statement on growth hormone therapy.
    Rosenfeld R, Hochberg Z, Albertsson-Wikland K, Gluckman P D, Kastrup K, Kauli R, Pescovitz O H, Price D A, Ranke M B, Rappaport R.
    Acta Paediatr Scand Suppl 1990:367:177-8.[Source: PubMed®]
    [Links: PMID: 2220383]
17. Endocrine basis for growth-promoting therapy.
    Albertsson-Wikland K.
    Acta Paediatr Scand Suppl 1990:367:11-3.[Source: PubMed®]
    [Links: PMID: 2220374]

Article - Peer reviewed scientific (254)

1. The use of bone age in clinical practice - part 1.
   Martin David D, Wit Jan M, Hochberg Ze'ev, Sävendahl Lars, van Rijn Rick R, Fricke Oliver, Cameron Noël, Caliebe Janina, Hertel Thomas, Kiepe Daniela, Albertsson-Wikland Kerstin, Thodberg Hans Henrik, Binder Gerhard, Ranke Michael B.
   Horm Res Paediatr 2011:76(1):1-9.[Source: PubMed®]
   [Links: PMID: 21691054 | DOI länk]
2. Long-term response to GH therapy in short children with a delayed infancy-childhood transition (DICT).
   Albertsson-Wikland Kerstin, Kriström Berit, Jonsson Björn, Hochberg Ze'ev.
   Pediatr Res. 2011:69(6):504-10.[Source: PubMed®]
   [Links: PMID: 21297523 | DOI länk]
3. Protein profiling identified dissociations between growth hormone-mediated longitudinal growth and bone mineralization in short prepubertal children.
   Andersson Björn, Decker Ralph, Nierop Andreas F M, Bosaeus Ingvar, Albertsson-Wikland Kerstin, Hellgren Gunnel.
   J Proteomics 2011:74(1):89-100.[Source: PubMed®]
   [Links: PMID: 20816880 | DOI länk]
4. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH-deficiency.
   Decker Ralph, Albertsson-Wikland Kerstin, Kriström Berit, Nierop Andreas F M, Gustafsson Jan, Bosaeus Ingvar, Fors Hans, Hochberg Ze'ev, Dahlgren Jovanna.
   Clinical endocrinology 2010[Source: PubMed®]
   [Links: PMID: 20455890 | DOI länk]
5. Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.
   Andersson Björn, Hellgren Gunnel, Nierop Andreas F M, Hochberg Ze'ev, Albertsson-Wikland Kerstin.
   Proteome Sci 2009:7:40.[Source: PubMed®]
   [Links: PMID: 19883510 | DOI länk]
6. Decrease in adiponectin levels correlates to growth response in growth hormone-treated children.
   Andersson B, Carlsson L M S, Carlsson B, Albertsson-Wikland K, Bjarnason R;
   Swedish Study Group for Growth Hormone Treatment.
   Horm Res. 2009:71(4):213-8.[Source: PubMed®]
   [Links: PMID: 19258713 | DOI länk]
7. Decrease in adiponectin levels correlates to growth response in growth hormone-treated children.
   Andersson B, Carlsson L M S, Carlsson B, Albertsson-Wikland K, Bjarnason R;
   Swedish Study Group for Growth Hormone Treatment.
   Horm Res. 2009:71(4):213-8.[Source: PubMed®]
   [Links: PMID: 19258713 | DOI länk]
8. The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children.
   Kriström Berit, Dahlgren Jovanna, Niklasson Aimon, Nierop Andreas F M, Albertsson-Wikland Kerstin.
   BMC medical informatics and decision making 2009:9:1.[Source: PubMed®]
   [Links: PMID: 19138407 | DOI länk]
9. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
   Kriström Berit, Aronson A Stefan, Dahlgren Jovanna, Gustafsson Jan, Halldin Maria, Ivarsson Sten A, Nilsson Nils-Osten, Svensson Johan, Tuvemo Torsten, Albertsson-Wikland Kerstin.
   J Clin Endocrinol Metab. 2009:94(2):483-90.[Source: PubMed®]
   [Links: PMID: 19001519 | DOI länk]
10. Idiopathic Short Stature – Evaluating Growth Results from Clinical Trials in the KIGS database. LWPES/ESPE,.
    Albertsson.Wikland Kerstin, Kriström B, Lindberg A.
    Hormone Research in Paediatrics 2009:72(Suppl 3):98.[Source: User]
11. Evaluation of the Prediction model used in a randomized GH dose study in short GHD and ISS children, with addition of KIGS SGA dose module.
    Albertsson.Wikland Kerstin, Kriström B, Nierop AFM.
    Hormone Research in Paediatrics 2009:72(Suppl 3):99.[Source: User]
12. Using a proteomics approach – protein expression patterns correlates with the growth response to growth hormone (GH) treatment in short prepubertal children.
    Andersson B, Hellgren G, Nierop AFM, Hochberg Z, Albertsson-Wikland Kerstin.
    Hormone Research in Paediatrics 2009:72(Suppl 3):161.[Source: User]
13. Physiological estrogen replacement therapy during mid-puberty in girls.
    Ankarberg-Lindgren C, Albertsson-Wikland Kerstin, Norjavaara E.
    Hormone Research in Paediatrics 2009:72(Suppl 3):122.[Source: User]
14. Perceptions of Stature and Self-Esteem in ISS children from start of GH treatment to Adult Height.
    Chaplin JE, Jonsson B, Albertsson-Wikland Kerstin.
    Hormone Research in Paediatrics 2009:72(Suppl 3):105.[Source: User]
15. Proteomics in GH-treated short Children – Dessociation between Proteins related to Longitudinal Growt, Bone Volume and Bone Mineralization.
    Hellgren G, Andersson B, Decker R, Nierop AFM, Bosaeus I, Albertsson-Wikland Kerstin.
    Hormone Research in Paediatrics 2009:72(Suppl 3):162.[Source: User]
16. Serum Insulin and IGF-I levels after 2 yrs of treatment with Individual GH doses (17-100 µg/kg/d) compared to standard dose (43 µg/kg/d) in prepubertal GHD and ISS children.
    Kriström B, Albertsson-Wikland Kerstin.
    Hormone Research in Paediatrics 2009:72(Suppl 3):256.[Source: User]
17. A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature.
    Hellgren Gunnel, Andersson Björn, Nierop Andreas Fm, Dahlgren Jovanna, Hochberg Ze'ev, Albertsson-Wikland Kerstin.
    Proteome science 2008:6:35.[Source: PubMed®]
    [Links: PMID: 19077222 | DOI länk]
18. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland Kerstin, Aronson A Stefan, Gustafsson Jan, Hagenäs Lars, Ivarsson Sten A, Jonsson Björn, Kriström Berit, Marcus Claude, Nilsson Karl Olof, Ritzén E Martin, Tuvemo Torsten, Westphal Otto, Aman Jan.
    J Clin Endocrinol Metab. 2008:93(11):4342-50.[Source: PubMed®]
    [Links: PMID: 18728172 | DOI länk]
19. Relative cardiac expression of growth hormone receptor and insulin-like growth factor-I mRNA in congenital heart disease.
    Nygren A, Sunnegårdh J, Albertsson-Wikland K, Berggren H, Isgaard J.
    J Endocrinol Invest. 2008:31(3):196-200.[Source: PubMed®]
    [Links: PMID: 18401200]
20. Growth promoting treatment normalizes speech frequency in Turner syndrome.
    Andersson-Wallgren Gunnel, Ohlsson Ann-Christine, Albertsson-Wikland Kerstin, Barrenäs Marie-Louise.
    Laryngoscope 2008:118(6):1125-30.[Source: PubMed®]
    [Links: PMID: 18354336 | DOI länk]
21. Continuous growth reference from 24th week of gestation to 24 months by gender.
    Niklasson Aimon, Albertsson-Wikland Kerstin.
    BMC pediatrics 2008:8:8.[Source: PubMed®]
    [Links: PMID: 18307822 | DOI länk]
22. Recent anthropometric trends among Swedish school children: evidence for decreasing prevalence of overweight in girls.
    Sjöberg Agneta, Lissner Lauren, Albertsson-Wikland Kerstin, Mårild Staffan.
    Acta Paediatr. 2008:97(1):118-23.[Source: PubMed®]
    [Links: PMID: 18201312 | DOI länk]
23. Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age.
    Dahlgren Jovanna, Kriström Berit, Niklasson Aimon, Nierop Andreas F M, Rosberg Sten, Albertsson-Wikland Kerstin.
    BMC medical informatics and decision making 2007:7:40.[Source: PubMed®]
    [Links: PMID: 18076760 | DOI länk]
24. Leptin levels at birth and in early postnatal life in small- and appropriate-for-gestational-age infants.
    Val Margarita, Verkauskiene Rasa, Boguszewski Margaret, Dahlgren Jovanna, Lasiene Danute, Lasas Liudvikas, Wikland Kerstin Albertsson.
    Medicina (Kaunas, Lithuania) 2007:43(10):784-91.[Source: PubMed®]
    [Links: PMID: 17998795]
25. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone.
    Kjellberg H, Wikland K Albertsson.
    Eur J Orthod 2007:29(3):243-50.[Source: PubMed®]
    [Links: PMID: 17513878 | DOI länk]
26. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke Michael B, Lindberg Anders, Price David A, Darendeliler Feyza, Albertsson-Wikland Kerstin, Wilton Patrick, Reiter Edward O;
    KIGS International Board.
    Horm Res. 2007:68(2):53-62.[Source: PubMed®]
    [Links: PMID: 17228181 | DOI länk]
27. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.
    Boguszewski Margaret C S, Kamoi Tsukiyo Obu, Bento Radominski Rosana, Boguszewski Cesar Luiz, Rosberg Sten, Filho Nelson Augusto Rosário, Sandrini Neto Romolo, Albertsson-Wikland Kerstin.
    Horm Res. 2007:67(5):250-6.[Source: PubMed®]
    [Links: PMID: 17215581 | DOI länk]
28. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke Michael B, Lindberg Anders, Ferrández Longás Angel, Darendeliler Feyza, Albertsson-Wikland Kerstin, Dunger David, Cutfield Wayne S, Tauber Maïthé, Wilton Patrick, Wollmann Hartmut A, Reiter Edward O;
    KIGS International Board.
    Pediatr Res. 2007:61(1):105-10.[Source: PubMed®]
    [Links: PMID: 17211150 | DOI länk]
29. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).
    Darendeliler Feyza, Karagiannis Georgios, Wilton Patrick, Ranke Michael B, Albertsson-Wikland Kerstin, Anthony Price David, On Behalf Of The Kigs International Board.
    Acta Paediatr. 2006:95(10):1284-90.[Source: PubMed®]
    [Links: PMID: 16982503 | DOI länk]
30. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig Maria E, Cowell Christopher T, Larsson Pontus, Zipf William B, Reiter Edward O, Albertsson Wikland Kerstin, Ranke Michael B, Price David A;
    KIGS International Board.
    Clin Endocrinol (Oxf) 2006:65(2):178-85.[Source: PubMed®]
    [Links: PMID: 16886957 | DOI länk]
31. GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.
    Svensson Johan, Johannsson Gudmundur, Iranmanesh Ali, Albertsson-Wikland Kerstin, Veldhuis Johannes D, Bengtsson Bengt-Ake.
    Eur J Endocrinol. 2006:155(1):91-9.[Source: PubMed®]
    [Links: PMID: 16793954 | DOI länk]
32. Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles.
    Mancini Marcio C, Costa Ana P A C, de Melo Maria Edna, Cercato Cintia, Giannella-Neto Daniel, Garrido Arthur B, Rosberg Sten, Albertsson-Wikland Kerstin, Villares Sandra M F, Halpern Alfredo.
    Obesity (Silver Spring) 2006:14(3):383-7.[Source: PubMed®]
    [Links: PMID: 16648608 | DOI länk]
33. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
    Reiter Edward O, Price David A, Wilton Patrick, Albertsson-Wikland Kerstin, Ranke Michael B.
    J Clin Endocrinol Metab. 2006:91(6):2047-54.[Source: PubMed®]
    [Links: PMID: 16537676 | DOI länk]
34. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio Deborah, Dahlgren Jovanna, Wikland Kerstin Albertsson, Westphal Otto.
    Acta Paediatr. 2005:94(9):1232-7.[Source: PubMed®]
    [Links: PMID: 16203673 | DOI länk]
35. Pediatric reference data for bone mineral density in the calcaneus for healthy children 2, 4, and 7 years of age by dual-energy x-ray absorptiometry and laser.
    Söderpalm A-C, Kullenberg R, Wikland K Albertsson, Swolin-Eide D.
    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2005:8(3):305-13.[Source: PubMed®]
    [Links: PMID: 16055961]
36. The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants.
    Engström Eva, Niklasson Aimon, Wikland Kerstin Albertsson, Ewald Uwe, Hellström Ann.
    Pediatr Res. 2005:57(4):605-10.[Source: PubMed®]
    [Links: PMID: 15695599 | DOI länk]
37. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke Michael B, Lindberg Anders, Albertsson-Wikland Kerstin, Wilton Patrick, Price David A, Reiter Edward O.
    J Clin Endocrinol Metab. 2005:90(4):1966-71.[Source: PubMed®]
    [Links: PMID: 15634724 | DOI länk]
38. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler Feyza, Ranke Michael B, Bakker Bert, Lindberg Anders, Cowell Christopher T, Albertsson-Wikland Kerstin, Reiter Edward O, Price David A.
    Horm Res. 2005:63(1):40-7.[Source: PubMed®]
    [Links: PMID: 15627781 | DOI länk]
39. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
    Löfqvist Chatarina, Andersson Eva, Gelander Lars, Rosberg Sten, Hulthen Lena, Blum Werner F, Wikland Kerstin Albertsson.
    J Clin Endocrinol Metab. 2005:90(3):1420-7.[Source: PubMed®]
    [Links: PMID: 15598696 | DOI länk]
40. Final height in short children born small for gestational age treated with growth hormone.
    Dahlgren Jovanna, Wikland Kerstin Albertsson;
    Swedish Study Group for Growth Hormone Treatment.
    Pediatr Res. 2005:57(2):216-22.[Source: PubMed®]
    [Links: PMID: 15585685 | DOI länk]
41. Prevalence trends of obesity and overweight among 10-year-old children in western Sweden and relationship with parental body mass index.
    Mårild S, Bondestam M, Bergström R, Ehnberg S, Hollsing A, Albertsson-Wikland K.
    Acta Paediatr. 2004:93(12):1588-95.[Source: PubMed®]
    [Links: PMID: 15841766]
42. Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experience.
    Ranke Michael B, Schweizer Roland, Lindberg Anders, Price David A, Reiter Edward O, Albertsson-Wikland Kerstin, Darendeliler Feyza.
    Horm Res. 2004:62:17-25.[Source: PubMed®]
    [Links: PMID: 15761228 | DOI länk]
43. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T, Jonsson B, Gustafsson J, Albertsson-Wikland K, Aronson A S, Häger A, Ivarson S, Kriström B, Marcus C, Nilsson K O, Westgren U, Westphal O, Aman J, Proos L A.
    Acta Paediatr. 2004:93(11):1456-62.[Source: PubMed®]
    [Links: PMID: 15513572 | DOI länk]
44. Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal children.
    Bjarnason R, Andersson B, Kim H S, Olsson B, Swolin-Eide D, Wickelgren R, Kriström B, Carlsson B, Albertsson-Wikland K, Carlsson L M S.
    J Clin Endocrinol Metab. 2004:89(10):5156-60.[Source: PubMed®]
    [Links: PMID: 15472220 | DOI länk]
45. Construction of a soluble human GH-receptor/EGF-receptor hybrid and its activation by GH.
    Hellgren G, Löfqvist C, Wikland K Albertsson, Carlsson B, Carlsson L M S.
    Cytokine 2004:25(6):260-4.[Source: PubMed®]
    [Links: PMID: 15036241 | DOI länk]
46. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair J C, Camacho-Hübner C, Miraki Moud F, Rosberg S, Burren C, Lim S, Clayton P E, Bjarnason R, Albertsson-Wikland K, Savage M O.
    Clin Endocrinol (Oxf) 2004:60(2):163-8; discussion 16.[Source: PubMed®]
    [Links: PMID: 14725676]
47. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.
    Hellström Ann, Engström Eva, Hård Anna-Lena, Albertsson-Wikland Kerstin, Carlsson Björn, Niklasson Aimon, Löfqvist Chatarina, Svensson Elisabeth, Holm Sture, Ewald Uwe, Holmström Gerd, Smith Lois E H.
    Pediatrics 2003:112(5):1016-20.[Source: PubMed®]
    [Links: PMID: 14595040]
48. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations.
    Johnston Linda B, Dahlgren Jovanna, Leger Juliane, Gelander Lars, Savage Martin O, Czernichow Paul, Wikland Kerstin Albertsson, Clark Adrian J L.
    J Clin Endocrinol Metab. 2003:88(10):4805-10.[Source: PubMed®]
    [Links: PMID: 14557458]
49. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
    Ranke Michael B, Lindberg Anders, Martin David D, Bakker Bert, Wilton Patrick, Albertsson-Wikland Kerstin, Cowell Chris T, Price David A, Reiter Edward O.
    J Clin Endocrinol Metab. 2003:88(10):4748-53.[Source: PubMed®]
    [Links: PMID: 14557450]
50. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter Edward O, Lindberg Anders, Ranke Michael B, Price David A, Albertsson-Wikland Kerstin, Cowell Christopher T, Bakker Bert.
    Horm Res. 2003:60(Suppl 1):68-73.[Source: PubMed®]
    [Links: PMID: 12955021 | DOI länk]
51. Growth in very preterm children: a longitudinal study.
    Niklasson Aimon, Engstrom Eva, Hard Anna-Lena, Wikland Kerstin Albertsson, Hellstrom Ann.
    Pediatr Res. 2003:54(6):899-905.[Source: PubMed®]
    [Links: PMID: 12930904 | DOI länk]
52. Short-term gluten challenge in children with coeliac disease does not impair spontaneous growth hormone secretion.
    Jansson Ulf H G, Kristiansson Bengt, Albertsson-Wikland Kerstin, Bjarnason Ragnar.
    J Pediatr Endocrinol Metab. 2003:16(5):771-8.[Source: PubMed®]
    [Links: PMID: 12880127]
53. Reference values for change in body mass index from birth to 18 years of age.
    Karlberg J, Kwan C W, Albertsson-Wikland K.
    Acta Paediatr. 2003:92(6):648-52.[Source: PubMed®]
    [Links: PMID: 12856971]
54. Parents' descriptions of development and problems associated with infants with Turner syndrome: a retrospective study.
    Starke M, Albertsson Wikland K, Möller A.
    J Paediatr Child Health 2003:39(4):293-8.[Source: PubMed®]
    [Links: PMID: 12755938]
55. Natural growth in children born SGA with and without catch up growth.
    Albertsson-Wikland Kerstin, Karlberg Johan.
    Horm Res. 2003:59:129.[Source: PubMed®]
    [Links: PMID: 12638524]
56. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
    Ranke Michael B, Lindberg Anders, Cowell Christopher T, Wikland Kerstin Albertsson, Reiter Edward O, Wilton Patrick, Price David A;
    KIGS International Board.
    J Clin Endocrinol Metab. 2003:88(1):125-31.[Source: PubMed®]
    [Links: PMID: 12519840]
57. Growth in early life and its relation to pubertal growth.
    Luo Zhong Cheng, Cheung Yin Bun, He Qing, Albertsson-Wikland Kerstin, Karlberg Johan.
    Epidemiology 2003:14(1):65-73.[Source: PubMed®]
    [Links: PMID: 12500048 | DOI länk]
58. Gene association studies in small for gestational age infants.
    Johnston Linda B, Arends Nicolette, Dahlgren Jovanna, Leger Juliane, Czernichow Paul, Albertsson-Wikland Kerstin, van Duijn C, Hokken-Koelega Anita, Savage Martin O, Clark Adrian J L.
    J Pediatr Endocrinol Metab. 2002:15:1459.[Source: PubMed®]
    [Links: PMID: 12511011]
59. A growth prediction model for short children born small for gestational age.
    Ranke Michael B, Cutfield Wayne S, Lindberg Anders, Cowell Christopher T, Albertsson-Wikland Kerstin, Reiter Edward O, Wilton Patrick, Price David A;
    KIGS International Board.
    J Pediatr Endocrinol Metab. 2002:15:1273.[Source: PubMed®]
    [Links: PMID: 12510978]
60. Early spontaneous catch-up growth.
    Karlberg Johan, Albertsson-Wikland Kerstin, Kwan Chi Wai, Chan Flora Y S.
    J Pediatr Endocrinol Metab. 2002:15:1243-55.[Source: PubMed®]
    [Links: PMID: 12510975]
61. Born small for gestational age: relation to future allergy and asthma.
    Hesselmar B, Dahlgren J, Wennergren G, Aberg N, Albertsson-Wiklan K.
    Acta Paediatr. 2002:91(9):992-4.[Source: PubMed®]
    [Links: PMID: 12412878]
62. Psychological functioning in boys of short stature: effects of different levels of growth hormone secretion.
    Erling A, Wiklun I, Albertsson Wikland K.
    Acta Paediatr. 2002:91(9):966-71.[Source: PubMed®]
    [Links: PMID: 12412874]
63. Benn Index at birth is associated with postnatal linear growth.
    Cheung Y B, Albertsson-Wikland K, Luo Z C, He Q, Karlberg J.
    J Pediatr Endocrinol Metab. 2002:15(8):1161-6.[Source: PubMed®]
    [Links: PMID: 12387514]
64. Affected skeletal growth but normal bone mineralization in rat offspring after prenatal dexamethasone exposure.
    Swolin-Eide Diana, Dahlgren J, Nilsson C, Albertsson Wikland K, Holmäng A, Ohlsson C.
    J Endocrinol. 2002:174(3):411-8.[Source: PubMed®]
    [Links: PMID: 12208661]
65. Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity.
    Bjarnason Ragnar, Banerjee Kausik, Rose Steven J, Rosberg Sten, Metherell Louise, Clark Adrian J L, Albertsson-Wikland Kerstin, Savage Martin O.
    Clin Endocrinol (Oxf) 2002:57(3):357-61.[Source: PubMed®]
    [Links: PMID: 12201828]
66. Body composition, as assessed by bioelectrical impedance spectroscopy and dual-energy X-ray absorptiometry, in a healthy paediatric population.
    Fors H, Gelander L, Bjarnason R, Albertsson-Wikland K, Bosaeus I.
    Acta Paediatr. 2002:91(7):755-60.[Source: PubMed®]
    [Links: PMID: 12200899]
67. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference.
    Wikland K Albertsson, Luo Z C, Niklasson A, Karlberg J.
    Acta Paediatr. 2002:91(7):739-54.[Source: PubMed®]
    [Links: PMID: 12200898]
68. Parents' experiences of receiving the diagnosis of Turner syndrome: an explorative and retrospective study.
    Starke Mikaela, Wikland Kerstin Albertsson, Möller Anders.
    Patient Educ Couns 2002:47(4):347-54.[Source: PubMed®]
    [Links: PMID: 12135826]
69. IGF-I is critical for normal vascularization of the human retina.
    Hellström Ann, Carlsson Björn, Niklasson Aimon, Segnestam Karin, Boguszewski Margaret, de Lacerda Luiz, Savage Martin, Svensson Elisabeth, Smith Lois, Weinberger Dov, Albertsson Wikland Kerstin, Laron Zvi.
    J Clin Endocrinol Metab. 2002:87(7):3413-6.[Source: PubMed®]
    [Links: PMID: 12107259]
70. Growth prediction models, concept and use.
    Kriström Berit, Wikland Kerstin Albertsson.
    Horm Res. 2002:57:66-70.[Source: PubMed®]
    [Links: PMID: 12065931]
71. Variation in size at birth in infants born small for gestational age in Lithuania.
    Verkauskiene R, Albertsson Wikland K, Niklasson A.
    Acta Paediatr. 2002:91(3):329-34.[Source: PubMed®]
    [Links: PMID: 12022308]
72. Short boys treated with growth hormone show normal progression of testicular size and achieve normal serum testosterone concentrations.
    Ankarberg-Lindgren Carina, Norjavaara Ensio, Wikland Kerstin Albertsson.
    Eur J Endocrinol. 2002:146(5):681-5.[Source: PubMed®]
    [Links: PMID: 11980624]
73. [A child's growth mirrors health and illness. Regular measurement of body height is an important diagnostic tool].
    Gelander Lars, Hagenäs Lars, Albertsson-Wikland Kerstin.
    Lakartidningen 2002:99(3):162-4.[Source: PubMed®]
    [Links: PMID: 11838071]
74. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson B A, Johannsson G.
    Clin Endocrinol (Oxf) 2001:55(5):617-24.[Source: PubMed®]
    [Links: PMID: 11894973]
75. Body mass index reference values (mean and SD) for Swedish children.
    Karlberg J, Luo Z C, Albertsson-Wikland K.
    Acta Paediatr. 2001:90(12):1427-34.[Source: PubMed®]
    [Links: PMID: 11853342]
76. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty.
    Löfqvist C, Andersson E, Gelander L, Rosberg S, Blum W F, Albertsson Wikland K.
    J Clin Endocrinol Metab. 2001:86(12):5870-6.[Source: PubMed®]
    [Links: PMID: 11739455]
77. Genetic analysis of mosaicism in 53 women with Turner syndrome.
    Hanson L, Bryman I, Barrenäs M L, Janson P O, Wahlström J, Albertsson-Wikland K, Hanson C.
    Hereditas 2001:134(2):153-9.[Source: PubMed®]
    [Links: PMID: 11732852]
78. The potential of prediction models based on data from KIGS as tools to measure responsiveness to growth hormone. Pharmacia International Growth Database.
    Ranke M B, Lindberg A, Chatelain P, Wilton P, Price D A, Albertsson-Wikland K;
    KIGS International Board.
    Horm Res. 2001:55:44-8.[Source: PubMed®]
    [Links: PMID: 11684876]
79. Effect of spontaneous GH secretion and the GH sampling period on the accuracy of models for predicting growth responses to GH treatment.
    Kriström B, Löfqvist C, Rosberg S, Albertsson Wikland K.
    J Clin Endocrinol Metab. 2001:86(10):4963-4.[Source: PubMed®]
    [Links: PMID: 11600570]
80. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls.
    Ankarberg-Lindgren C, Elfving M, Wikland K A, Norjavaara E.
    J Clin Endocrinol Metab. 2001:86(7):3039-44.[Source: PubMed®]
    [Links: PMID: 11443165]
81. Prenatal cytokine exposure results in obesity and gender-specific programming.
    Dahlgren J, Nilsson C, Jennische E, Ho H P, Eriksson E, Niklasson A, Björntorp P, Albertsson Wikland K, Holmäng A.
    Am J Physiol Endocrinol Metab. 2001:281(2):E326-34.[Source: PubMed®]
    [Links: PMID: 11440909]
82. Leptin levels show diurnal variation throughout puberty in healthy children, and follow a gender-specific pattern.
    Ankarberg-Lindgren C, Dahlgren J, Carlsson B, Rosberg S, Carlsson L, Wikland K A, Norjavaara E.
    Eur J Endocrinol. 2001:145(1):43-51.[Source: PubMed®]
    [Links: PMID: 11415851]
83. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.
    Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard A L, Liu J L, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger D R, Smith L E.
    Proc Natl Acad Sci U.S.A. 2001:98(10):5804-8.[Source: PubMed®]
    [Links: PMID: 11331770 | DOI länk]
84. The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease.
    Jansson U H, Kristiansson B, Magnusson P, Larsson L, Albertsson-Wikland K, Bjarnason R.
    Eur J Endocrinol. 2001:144(4):417-23.[Source: PubMed®]
    [Links: PMID: 11275953]
85. Growth hormone receptor interaction with Jak proteins differs between tissues.
    Hellgren G, Albertsson-Wikland K, Billig H, Carlsson L M, Carlsson B.
    J Interferon Cytokine Res. 2001:21(2):75-83.[Source: PubMed®]
    [Links: PMID: 11244571 | DOI länk]
86. Serum leptin in short children born small for gestational age: dose-dependent effect of growth hormone treatment.
    Boguszewski M C, de Zegher F, Albertsson-Wikland K;
    Nordic Study Group for Growth Hormone Treatment in SGA Children and the Belgian Study Group for Pediatric Endocrinology.
    Horm Res. 2000:54(3):120-5.[Source: PubMed®]
    [Links: PMID: 11357004]
87. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke M B, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price D A;
    KIGS International Board. Kabi International Growth Study.
    J Clin Endocrinol Metab. 2000:85(11):4212-8.[Source: PubMed®]
    [Links: PMID: 11095456]
88. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.
    Growth Hormone Research Society.
    J Clin Endocrinol Metab. 2000:85(11):3990-3.[Source: PubMed®]
    [Links: PMID: 11095419]
89. Craniofacial morphology, dental occlusion, tooth eruption, and dental maturity in boys of short stature with or without growth hormone deficiency.
    Kjellberg H, Beiring M, Albertsson Wikland K.
    Eur J Oral Sci. 2000:108(5):359-67.[Source: PubMed®]
    [Links: PMID: 11037751]
90. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities.
    Wikland K A, Kriström B, Rosberg S, Svensson B, Nierop A F.
    Pediatr Res. 2000:48(4):475-84.[Source: PubMed®]
    [Links: PMID: 11004238]
91. Family function in families with children of normal height and in families with short children.
    Starke M, Erling A, Möller A, Wikland K A.
    Acta Paediatr. 2000:89(8):983-8.[Source: PubMed®]
    [Links: PMID: 10976844]
92. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F, Albertsson-Wikland K, Wollmann H A, Chatelain P, Chaussain J L, Löfström A, Jonsson B, Rosenfeld R G.
    J Clin Endocrinol Metab. 2000:85(8):2816-21.[Source: PubMed®]
    [Links: PMID: 10946888]
93. New reference for the age at childhood onset of growth and secular trend in the timing of puberty in Swedish.
    Liu Y X, Wikland K A, Karlberg J.
    Acta Paediatr. 2000:89(6):637-43.[Source: PubMed®]
    [Links: PMID: 10914954]
94. Children with septo-optic dysplasia - how to improve and sharpen the diagnosis.
    Hellström A, Aronsson M, Axelson C, Kyllerman M, Kopp S, Steffenburg S, Strömland K, Westphal O, Wiklund L, Albertsson Wikland K.
    Horm Res. 2000:53:19-25.[Source: PubMed®]
    [Links: PMID: 10895038]
95. Population-based body mass index reference values from Göteborg, sweden: birth to 18 years of age.
    He Q, Albertsson-Wikland K, Karlberg J.
    Acta Paediatr. 2000:89(5):582-92.[Source: PubMed®]
    [Links: PMID: 10852197]
96. Long-term consequences of early linear growth retardation (stunting) in Swedish children.
    Liu Y, Albertsson-Wikland K, Karlberg J.
    Pediatr Res. 2000:47(4 Pt 1):475-80.[Source: PubMed®]
    [Links: PMID: 10759154]
97. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.
    Cutfield W S, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke M B, Price D A.
    Lancet 2000:355(9204):610-3.[Source: PubMed®]
    [Links: PMID: 10696981 | DOI länk]
98. Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models. KIGS International Board. Kabi International Growth Study.
    Ranke M B, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price D A.
    Acta Paediatr Suppl 1999:88(433):122-5.[Source: PubMed®]
    [Links: PMID: 10626562]
99. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G, Albertsson-Wikland K, Bengtsson B A.
    J Clin Endocrinol Metab. 1999:84(12):4516-24.[Source: PubMed®]
    [Links: PMID: 10599711]
100. Serum leptin levels correlate with growth hormone secretion and body fat in children.
     Fors H, Matsuoka H, Bosaeus I, Rosberg S, Wikland K A, Bjarnason R.
     J Clin Endocrinol Metab. 1999:84(10):3586-90.[Source: PubMed®]
     [Links: PMID: 10523000]
101. Prevalence of coeliac disease in Turner syndrome.
     Ivarsson S A, Carlsson A, Bredberg A, Alm J, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Kriström B, Marcus C, Moëll C, Nilsson K O, Tuvemo T, Westphal O, Albertsson-Wikland K, Aman J.
     Acta Paediatr. 1999:88(9):933-6.[Source: PubMed®]
     [Links: PMID: 10519331]
102. Optic nerve hypoplasia with isolated tortuosity of the retinal veins: a marker of endocrinopathy.
     Hellström A, Wiklund L M, Svensson E, Albertsson-Wikland K, Strömland K.
     Arch Ophthalmol. 1999:117(7):880-4.[Source: PubMed®]
     [Links: PMID: 10408451]
103. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
     Ranke M B, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price D A.
     J Clin Endocrinol Metab. 1999:84(4):1174-83.[Source: PubMed®]
     [Links: PMID: 10199749]
104. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
     Albertsson Wikland K, Alm F, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S, Kriström B, Marcus C, Moëll C, Nilsson K O, Ritzén M, Tuvemo T, Westgren U, Westphal O, Aman J.
     Acta Paediatr Suppl 1999:88(428):80-4.[Source: PubMed®]
     [Links: PMID: 10102059]
105. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
     Cutfield W, Lindberg A, Albertsson Wikland K, Chatelain P, Ranke M B, Wilton P.
     Acta Paediatr Suppl 1999:88(428):72-5.[Source: PubMed®]
     [Links: PMID: 10102057]
106. Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study.
     Gelander L, Blum W F, Larsson L, Rosberg S, Albertsson-Wikland K.
     Pediatr Res. 1999:45(3):377-83.[Source: PubMed®]
     [Links: PMID: 10088658]
107. Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.
     Matsuoka H, Fors H, Bosaeus I, Rosberg S, Albertsson-Wikland K, Bjarnason R.
     Eur J Endocrinol. 1999:140(1):35-42.[Source: PubMed®]
     [Links: PMID: 10037249]
108. Reduced retinal vascularization in children with growth hormone deficiency.
     Hellström A, Svensson E, Carlsson B, Niklasson A, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1999:84(2):795-8.[Source: PubMed®]
     [Links: PMID: 10022455]
109. Variations in glucocorticoid levels within the physiological range affect plasma leptin levels.
     Elimam A, Knutsson U, Brönnegård M, Stierna P, Albertsson-Wikland K, Marcus C.
     Eur J Endocrinol. 1998:139(6):615-20.[Source: PubMed®]
     [Links: PMID: 9916867]
110. Adrenal steroid hormones in short children born small for gestational age.
     Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K.
     Clin Endocrinol (Oxf) 1998:49(3):353-61.[Source: PubMed®]
     [Links: PMID: 9861327]
111. Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age.
     Luo Z C, Albertsson-Wikland K, Karlberg J.
     Pediatrics 1998:102(6):E72.[Source: PubMed®]
     [Links: PMID: 9832600]
112. Target height as predicted by parental heights in a population-based study.
     Luo Z C, Albertsson-Wikland K, Karlberg J.
     Pediatr Res. 1998:44(4):563-71.[Source: PubMed®]
     [Links: PMID: 9773847]
113. Children born small-for-gestational age: postnatal growth and hormonal status.
     Albertsson-Wikland K, Boguszewski M, Karlberg J.
     Horm Res. 1998:49:7-13.[Source: PubMed®]
     [Links: PMID: 9730665]
114. Children born small-for-gestational age: postnatal growth and hormonal status .
     Albertsson-Wikland K, Boguszewski M, Karlberg J.
     Horm Res. 1998:49(# Suppl 2):7-13.[Source: PubMed®]
     [Links: PMID: 9716820]
115. Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment.
     Kriström B, Carlsson B, Rosberg S, Carlsson L M, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1998:83(8):2735-41.[Source: PubMed®]
     [Links: PMID: 9709940]
116. Postnatal growth and health in children born after cryopreservation as embryos.
     Wennerholm U B, Albertsson-Wikland K, Bergh C, Hamberger L, Niklasson A, Nilsson L, Thiringer K, Wennergren M, Wikland M, Borres M P.
     Lancet 1998:351(9109):1085-90.[Source: PubMed®]
     [Links: PMID: 9660577 | DOI länk]
117. Midline brain lesions in children with hormone insufficiency indicate early prenatal damage.
     Hellström A, Wiklund L M, Svensson E, Strömland K, Albertsson-Wikland K.
     Acta Paediatr. 1998:87(5):528-36.[Source: PubMed®]
     [Links: PMID: 9641734]
118. Psychological aspects of Turner syndrome.
     Boman U W, Möller A, Albertsson-Wikland K.
     Journal of psychosomatic obstetrics and gynaecology 1998:19(1):1-18.[Source: PubMed®]
     [Links: PMID: 9575464]
119. Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial.
     Boguszewski M, Albertsson-Wikland K, Aronsson S, Gustafsson J, Hagenäs L, Westgren U, Westphal O, Lipsanen-Nyman M, Sipilä I, Gellert P, Müller J, Madsen B.
     Acta Paediatr. 1998:87(3):257-63.[Source: PubMed®]
     [Links: PMID: 9560030]
120. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.
     Price D A, Wilton P, Jönsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke M B.
     Horm Res. 1998:49(2):91-7.[Source: PubMed®]
     [Links: PMID: 9485178]
121. Growth hormone-binding protein levels over one year in healthy prepubertal children: intraindividual variation and correlation with height velocity.
     Gelander L, Bjarnason R, Carlsson L M, Albertsson-Wikland K.
     Pediatr Res. 1998:43(2):256-61.[Source: PubMed®]
     [Links: PMID: 9475294]
122. Overnight urinary growth hormone in normally growing prepubertal children: effect of urine volume. The one-year growth study.
     Gelander L, Karlberg J P, Larsson L A, Rosberg S, Albertsson-Wikland K.
     Horm Res. 1998:49(1):8-16.[Source: PubMed®]
     [Links: PMID: 9438779]
123. Serum leptin concentrations in relation to pubertal development.
     Carlsson B, Ankarberg C, Rosberg S, Norjavaara E, Albertsson-Wikland K, Carlsson L M.
     Arch Dis Child. 1997:77(5):396-400.[Source: PubMed®]
     [Links: PMID: 9487960]
124. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
     de Zegher F, Butenandt O, Chatelain P, Albertsson-Wikland K, Jonsson B, Löfström A, Chaussain J L.
     Acta Paediatr Suppl 1997:423:207-12.[Source: PubMed®]
     [Links: PMID: 9401574]
125. Hormonal status of short children born small for gestational age.
     Boguszewski M, Bjarnason R, Jansson C, Rosberg S, Albertsson-Wikland K.
     Acta Paediatr Suppl 1997:423:189-92.[Source: PubMed®]
     [Links: PMID: 9401570]
126. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
     Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson L M, Carlsson B, Albertsson-Wikland K.
     Eur J Endocrinol. 1997:137(4):387-95.[Source: PubMed®]
     [Links: PMID: 9368507]
127. Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment.
     Rongen-Westerlaken C, Corel L, van den Broeck J, Massa G, Karlberg J, Albertsson-Wikland K, Naeraa R W, Wit J M.
     Acta Paediatr. 1997:86(9):937-42.[Source: PubMed®]
     [Links: PMID: 9343271]
128. Circulating non-22 kDa growth hormone isoforms in healthy children of normal stature: relation to height, body mass and pubertal development.
     Boguszewski C L, Jansson C, Boguszewski M C, Rosberg S, Wikland K A, Carlsson B, Carlsson L M.
     Eur J Endocrinol. 1997:137(3):246-53.[Source: PubMed®]
     [Links: PMID: 9330588]
129. Changes in the isoforms of luteinizing hormone and follicle-stimulating hormone during puberty in normal children.
     Phillips D J, Albertsson-Wikland K, Eriksson K, Wide L.
     J Clin Endocrinol Metab. 1997:82(9):3103-6.[Source: PubMed®]
     [Links: PMID: 9284752]
130. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
     Boguszewski C L, Jansson C, Boguszewski M C, Rosberg S, Carlsson B, Albertsson-Wikland K, Carlsson L M.
     J Clin Endocrinol Metab. 1997:82(9):2944-9.[Source: PubMed®]
     [Links: PMID: 9284724]
131. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
     Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1997:82(9):2889-98.[Source: PubMed®]
     [Links: PMID: 9284715]
132. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
     Ranke M B, Price D A, Albertsson-Wikland K, Maes M, Lindberg A.
     Horm Res. 1997:48(2):62-71.[Source: PubMed®]
     [Links: PMID: 9251922]
133. Increased LH and FSH secretion after cranial irradiation in boys.
     Lannering B, Rosberg S, Albertsson-Wikland K, Albertsson-Wikland K.
     Med Pediatr Oncol. 1997:29(4):280-7.[Source: PubMed®]
     [Links: PMID: 9251734]
134. Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children.
     Bjarnason R, Boguszewski M, Dahlgren J, Gelander L, Kriström B, Rosberg S, Carlsson B, Albertsson-Wikland K, Carlsson L M.
     Eur J Endocrinol. 1997:137(1):68-73.[Source: PubMed®]
     [Links: PMID: 9242204]
135. Influence of gender on the correlation between plasma growth hormone profiles and urinary growth hormone excretion.
     Main K M, Jansson C, Skakkebak N, Albertsson-Wikland K.
     Horm Res. 1997:48(1):16-22.[Source: PubMed®]
     [Links: PMID: 9195205]
136. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein.
     Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K.
     Clin Chem. 1997:43(6 Pt 1):950-6.[Source: PubMed®]
     [Links: PMID: 9191545]
137. Growth hormone treatment induces a dose-dependent catch-up growth in short children born small for gestational age: a summary of four clinical trials.
     Wilton P, Albertsson-Wikland K, Butenandt O, Chaussain J L, de Zegher F, Jonsson B, Löfström A.
     Horm Res. 1997:48:67-71.[Source: PubMed®]
     [Links: PMID: 9161875]
138. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age.
     Karlberg J P, Albertsson-Wikland K, Kwan E Y, Lam B C, Low L C.
     Horm Res. 1997:48:17-24.[Source: PubMed®]
     [Links: PMID: 9161867]
139. Ocular fundus morphology in preterm children. Influence of gestational age, birth size, perinatal morbidity, and postnatal growth.
     Hellström A, Hård A L, Chen Y, Niklasson A, Albertsson-Wikland K.
     Invest Ophthalmol Vis Sci. 1997:38(6):1184-92.[Source: PubMed®]
     [Links: PMID: 9152238]
140. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
     Boguszewski M, Bjarnason R, Rosberg S, Carlsson L M, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1997:82(4):1014-9.[Source: PubMed®]
     [Links: PMID: 9100566]
141. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys.
     Albertsson-Wikland K, Rosberg S, Lannering B, Dunkel L, Selstam G, Norjavaara E.
     J Clin Endocrinol Metab. 1997:82(2):541-9.[Source: PubMed®]
     [Links: PMID: 9024251]
142. Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development.
     Knutsson U, Dahlgren J, Marcus C, Rosberg S, Brönnegård M, Stierna P, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1997:82(2):536-40.[Source: PubMed®]
     [Links: PMID: 9024250]
143. Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma.
     Samuelsson B O, Márky I, Rosberg S, Albertsson-Wikland K.
     Med Pediatr Oncol. 1997:28(1):27-34.[Source: PubMed®]
     [Links: PMID: 8950333]
144. Use of hGH for promotion of growth in normal short children: the Swedish experience.
     Albertsson-Wikland Kerstin.
     Clin Courier 1997:16(27):19-20.[Source: User]
145. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies.
     de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Löfström A, Butenandt O, Chaussain J L.
     Acta Paediatr Suppl 1996:417:27-31.[Source: PubMed®]
     [Links: PMID: 9055905]
146. Growth hormone status in six children with fetal alcohol syndrome.
     Hellström A, Jansson C, Boguszewski M, Olegård R, Laegreid L, Albertsson-Wikland K.
     Acta Paediatr. 1996:85(12):1456-62.[Source: PubMed®]
     [Links: PMID: 9001658]
147. Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay.
     Norjavaara E, Ankarberg C, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1996:81(11):4095-102.[Source: PubMed®]
     [Links: PMID: 8923866]
148. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
     Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1996:81(11):3902-8.[Source: PubMed®]
     [Links: PMID: 8923836]
149. Boy with a ring 7 chromosome: a case report with special reference to dermatological findings.
     Wahlström J, Bjarnason R, Rosdahl I, Albertsson-Wikland K.
     Acta Paediatr. 1996:85(10):1256-60.[Source: PubMed®]
     [Links: PMID: 8922097]
150. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
     Nilsson K O, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S A, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
     J Clin Endocrinol Metab. 1996:81(2):635-40.[Source: PubMed®]
     [Links: PMID: 8636281]
151. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
     Wide L, Albertsson-Wikland K, Phillips D J.
     J Clin Endocrinol Metab. 1996:81(1):216-21.[Source: PubMed®]
     [Links: PMID: 8550754]
152. Influence of standard preparations, conversion factors, GH heterogeneity, antibody characteristics and GH binding protein (GHBP) on growth hormone (GH) assays.
     JAnsson C, Boguszewski C, Rosberg S, Carlsson LMS, Albertsson-Wikland Kerstin.
     Hormone research 1996:46(Suppl 2):30-30.[Source: User]
153. Growth hormone binding protein in prepubertal short children born small for gestational age (SGA) effects of growth hormone treatment.
     Boguszewski MCS, Bjarnason R, Carlsson LMS, Albertsson-Wikland Kerstin.
     Hormone research 1996:46(Suppl 2):14-14.[Source: User]
154. Evaluation of the predictive value of growth and biochemical parameters in prepubertal children with various growth hormone (GH)-status in growth response to GH-treatment.
     Kriström B, Jansson C, Svensson B, Rosberg S, Albertsson-Wikland Kerstin.
     Hormone research 1996:46(Suppl 2):33-33.[Source: User]
155. Circadian cortisol rhythms in relation to age, growth, body composition, and pubertal development in healthy boys and girls.
     Dahlgren J, Knutsson U, Rosberg S, Stierna P, Brönnegård M, Marcus C, Albertsson-Wikland Kerstin.
     Hormone research 1996:46(Suppl 2):22-22.[Source: User]
156. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
     Sjöblom K, Albertsson-Wikland K, Bengtsson B A, Johannsson G, Thorén M, Degerblad M, Savage M O.
     Acta Paediatr Suppl 1995:411:63-5.[Source: PubMed®]
     [Links: PMID: 8563072]
157. Growth in full-term small-for-gestational-age infants: from birth to final height.
     Karlberg J, Albertsson-Wikland K.
     Pediatr Res. 1995:38(5):733-9.[Source: PubMed®]
     [Links: PMID: 8552442]
158. Thyroid autoantibodies, Turner's syndrome and growth hormone therapy.
     Ivarsson S A, Ericsson U B, Nilsson K O, Gustafsson J, Hagenäs L, Häger A, Moell C, Tuvemo T, Westphal O, Albertsson-Wikland K.
     Acta Paediatr. 1995:84(1):63-5.[Source: PubMed®]
     [Links: PMID: 7734902]
159. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
     Kriström B, Karlberg J, Albertsson-Wikland K.
     Acta Paediatr. 1995:84(1):51-7.[Source: PubMed®]
     [Links: PMID: 7734899]
160. Reduced growth hormone secretion with maintained periodicity following cranial irradiation in children with acute lymphoblastic leukaemia.
     Lannering B, Rosberg S, Marky I, Moëll C, Albertsson-Wikland K.
     Clin Endocrinol (Oxf) 1995:42(2):153-9.[Source: PubMed®]
     [Links: PMID: 7704959]
161. Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children.
     Bjarnason R, Albertsson-Wikland K, Carlsson L M.
     J Clin Endocrinol Metab. 1995:80(9):2756-60.[Source: PubMed®]
     [Links: PMID: 7673420]
162. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
     Boguszewski M, Rosberg S, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1995:80(9):2599-606.[Source: PubMed®]
     [Links: PMID: 7673401]
163. Intranasal delivery of human growth hormone - optimization of formulation.
     Albertsson-Wikland Kerstin, Hedin L, Jansson C, Rosberg S, Wikström C.
     Search ResultsDrug Development Research 1995:34:353-60.[Source: User]
164. Alkaline phosphatase bone isoforms in serum predicts growth response to growth hormone therapy in prepubertal short children.
     Larsson B, Magnus P, Larsson L, Häger A, Rosberg S, Albertsson-Wikland Kerstin.
     Endocrinology and Metabolism 1995:2(Suppl B):155-155.[Source: User]
165. IGF-I/IGFBP-3 basal levels and increase due to growth hormone treatment in prepubertal short children, related to a Swedish reference material of children of normal stature.
     Jansson C, Kriström B, Rosberg S, Blum W, Albertsson-Wikland Kerstin.
     Endocrinology and Metabolism 1995:2(Suppl B):156-156.[Source: User]
166. Spontaneous 24-hour growth hormone profile in prepubertal SGA children.
     Boguszewski M, Rosberg S, Albertsson-Wikland Kerstin.
     Hormone research 1995:44(Suppl 1):20-20.[Source: User]
167. On the construction of urine growth hormone (GH) reference values; its importance for an appropriate assessment of the slowly growing child.
     Gelander Lars, Larsson L, Karlberg J, Albertsson-Wikland Kerstin.
     Hormone research 1995:44(Suppl 1):31-31.[Source: User]
168. Final height (fHT) to GH therapy in idiopathic GHD (IGHD) - implications of early onset, good first year response and optimal pubertal growth.
     Ranke MB, Lindberg A, Maes M, Albertsson-Wikland Kerstin.
     Hormone research 1995:44(Suppl 1):57-57.[Source: User]
169. Circulating growth hormone isoforms in girls with Turner's syndrome.
     Blethen S L, Albertsson-Wikland K, Faklis E J, Chasalow F I.
     J Clin Endocrinol Metab. 1994:78(6):1439-43.[Source: PubMed®]
     [Links: PMID: 8200948]
170. Normal weight for length in newborn infants in whom growth hormone deficiency was later diagnosed. Swedish Paediatric Study Group for GH Treatment.
     Niklasson A, Karlberg P, Albertsson-Wikland K.
     Acta Paediatr. 1994:83(2):192-5.[Source: PubMed®]
     [Links: PMID: 8193501]
171. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty.
     Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T.
     J Clin Endocrinol Metab. 1994:78(5):1195-201.[Source: PubMed®]
     [Links: PMID: 8175978]
172. Change in speaking fundamental frequency in hormone-treated patients with Turner's syndrome--a longitudinal study of four cases.
     Andersson-Wallgren G, Albertsson-Wikland K.
     Acta Paediatr. 1994:83(4):452-5.[Source: PubMed®]
     [Links: PMID: 8025411]
173. Assay systems for the growth hormone-binding protein.
     Carlsson L, Mercado M, Baumann G, Stene M, Attie K, Reichert M, Albertsson-Wikland K, Dawson K, Wong W L.
     Proc Soc Exp Biol Med. 1994:206(3):312-5.[Source: PubMed®]
     [Links: PMID: 8016171]
174. [Final growth in girls with Turner's syndrome receiving treatment with growth hormone. Analysis of the international database for monitoring growth of the firm "Kabi Pharmaceutics" (KIGS)].
     Albertsson-Wikland K A.
     Probl Endokrinol (Mosk) 1994:40(4):81-6.[Source: PubMed®]
     [Links: PMID: 7971919]
175. Natural growth in children born small for gestational age with and without catch-up growth.
     Albertsson-Wikland K, Karlberg J.
     Acta Paediatr Suppl 1994:399:64-70; discussion 71.[Source: PubMed®]
     [Links: PMID: 7949620]
176. Effect of growth hormone treatment on insulin secretion and glucose metabolism in prepubertal boys with short stature.
     Aman J, Rosberg S, Albertsson-Wikland K.
     Eur J Endocrinol. 1994:131(3):246-50.[Source: PubMed®]
     [Links: PMID: 7921208]
177. A new self-assessment questionnaire to measure well-being in children, particularly those of short stature.
     Wiklund I, Wirén L, Erling A, Karlberg J, Albertsson-Wikland K.
     Qual Life Res 1994:3(6):449-55.[Source: PubMed®]
     [Links: PMID: 7866363]
178. Prepubertal children with short stature have a different perception of their well-being and stature than their parents.
     Erling A, Wiklund I, Albertsson-Wikland K.
     Qual Life Res 1994:3(6):425-9.[Source: PubMed®]
     [Links: PMID: 7866360]
179. Seasonality in lower leg length velocity in prepubertal children.
     Gelander L, Karlberg J, Albertsson-Wikland K.
     Acta Paediatr. 1994:83(12):1249-54.[Source: PubMed®]
     [Links: PMID: 7734863]
180. Prediction of final height in short, normal and tall children.
     Karlberg J, Lawrence C, Albertsson-Wikland K.
     Acta Paediatr Suppl 1994:406:3-9; discussion 10.[Source: PubMed®]
     [Links: PMID: 7734809]
181. Estimation of growth hormone secretory patterns in children with use of a numerical deconvolution technique: experimental design with use of computer simulation.
     Groth T, Rosberg S, Albertsson-Wikland K.
     Horm Res. 1994:42(6):245-52.[Source: PubMed®]
     [Links: PMID: 7698718]
182. Growth Hormone (GH) isoforms in Turner Syndrome.
     Blethen SL, Albertsson-Wikland Kerstin, Faklis EJ, Chasalow FI.
     Endocrinology and Metabolism 1994:1[Source: User]
183. Psychosocial aspects of short stature and growth hormone (GH) deficiency.
     Erling A, Wiklund I, Albertsson-Wikland Kerstin.
     Hormone research 1994:411:73-73.[Source: User]
184. Gonadotropin and estradiol secretion in girls during puberty.
     Norjavaara E, Rosberg S, Albertsson-Wikland Kerstin.
     Hormone research 1994:41:122-122.[Source: User]
185. Plasma growth hormone binding protein (GHBP) levels after a sc injection of GH in GH treated children.
     Bjarnason R, Albertsson-Wikland Kerstin, Calsson L.
     Hormone research 1994:41:91-91.[Source: User]
186. Contribution of pubertal growth to total growth in idiopathic growth hormone deficiency: Analysis of 96 cases from KIGS.
     Ranke MB, Lindberg A, Albertsson-Wikland Kerstin, Maes M, Price DA.
     Hormone research 1994:41:91-91.[Source: User]
187. Longitudinal follow-up of growth in children born small for gestational age.
     Albertsson-Wikland K, Wennergren G, Wennergren M, Vilbergsson G, Rosberg S.
     Acta Paediatr. 1993:82(5):438-43.[Source: PubMed®]
     [Links: PMID: 8518519]
188. Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
     Hedin L, Olsson B, Diczfalusy M, Flyg C, Petersson A S, Rosberg S, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1993:76(4):962-7.[Source: PubMed®]
     [Links: PMID: 8473411]
189. Time-resolved immunofluorometric assay of human growth hormone.
     Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A.
     Clin Chem. 1993:39(8):1620-5.[Source: PubMed®]
     [Links: PMID: 8353947]
190. Analysis of 24-hour plasma profiles of growth hormone (GH)-binding protein, GH/GH-binding protein-complex, and GH in healthy children.
     Carlsson L M, Rosberg S, Vitangcol R V, Wong W L, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1993:77(2):356-61.[Source: PubMed®]
     [Links: PMID: 8345039]
191. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.
     Albertsson-Wikland K.
     Acta Paediatr Suppl 1993:82:75-8.[Source: PubMed®]
     [Links: PMID: 8219481]
192. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
     Price D A, Albertsson-Wikland K.
     Acta Paediatr Suppl 1993:82:69-74.[Source: PubMed®]
     [Links: PMID: 8219480]
193. Silver-like syndrome and a small deletion on chromosome 13.
     Wahlström J, Holmgren G, Albertsson-Wikland K, Törnhage C J.
     Acta Paediatr. 1993:82(11):993-6.[Source: PubMed®]
     [Links: PMID: 8111185]
194. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion.
     Blum W F, Albertsson-Wikland K, Rosberg S, Ranke M B.
     J Clin Endocrinol Metab. 1993:76(6):1610-6.[Source: PubMed®]
     [Links: PMID: 7684744]
195. The short-term increases of IGF-I and IGFBP-3 during GH treatment predict the long-term growth response in short children.
     Blum WF, Rosberg S, Ranke MB, Albertsson-Wikland Kerstin.
     Pediatric research 1993:33(Suppl 5):48-48.[Source: User]
196. Spontaneous growth and final height in SGA infants.
     Karlberg J, Albertsson-Wikland Kerstin.
     Pediatric research 1993:33(Suppl 5):53-53.[Source: User]
197. Suspension of seasonality in growth velocity during growth hormone therapy in short children.
     Gelander L, Karlberg J, Albertsson-Wikland Kerstin.
     Pediatric research 1993:33(Suppl 3):53-53.[Source: User]
198. Growth hormone secretion in healthy children is not a main determinant of body composition measured as bioelectrical impedans.
     Bjarnason R, Rosberg S, Bosaeus I, Albertsson-Wikland Kerstin.
     Pediatric research 1993:33(Suppl 5):54-54.[Source: User]
199. Developmental changes in 24-hour profiles of luteinizing hormone and follicle-stimulating hormone from prepuberty to midstages of puberty in boys.
     Dunkel L, Alfthan H, Stenman U H, Selstam G, Rosberg S, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1992:74(4):890-7.[Source: PubMed®]
     [Links: PMID: 1548356]
200. Reproducibility of 24-h growth hormone profiles in children.
     Albertsson-Wikland K, Rosberg S.
     Acta Endocrinol. 1992:126(2):109-12.[Source: PubMed®]
     [Links: PMID: 1543014]
201. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study.
     Gluckman P D, Gunn A J, Wray A, Cutfield W S, Chatelain P G, Guilbaud O, Ambler G R, Wilton P, Albertsson-Wikland K.
     J Pediatr. 1992:121(6):920-3.[Source: PubMed®]
     [Links: PMID: 1447657]
202. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia.
     Màrky I, Mellander L, Lannering B, Albertsson-Wikland K.
     Med Pediatr Oncol. 1991:19(4):258-64.[Source: PubMed®]
     [Links: PMID: 2056970]
203. Growth hormone treatment and diabetes: survey of the kabi pharmacia international growth study.
     Czernichow P, Albertsson-Wikland K, Tuvemo T, Gunnarsson R.
     Acta Paediatr Scand Suppl 1991:379:104-7; discussion 10.[Source: PubMed®]
     [Links: PMID: 1815450]
204. How should the psychosocial impact of short stature and response to growth hormone treatment be assessed in children?
     Wiklund I, Albertsson-Wikland K, Wiren L.
     Acta Paediatr Scand Suppl 1991:377:174-5.[Source: PubMed®]
     [Links: PMID: 1785311]
205. Growth in infancy and childhood in girls with Turner's syndrome.
     Karlberg J, Albertsson-Wikland K, Nilsson K O, Ritzén E M, Westphal O.
     Acta Paediatr Scand 1991:80(12):1158-65.[Source: PubMed®]
     [Links: PMID: 1785288]
206. Tillväxt och tillväxthormoninsöndring hos benmärgstransplanterade barn.
     Borgström B, Albertsson-Wikland Kerstin, Bolme P.
     Acta Soc Med Suec 1991:100(2):299-299.[Source: User]
207. Urinary measurement of growth hormone secretion.
     Girard J, Celniker A, Price A, Tanaka T, Walker J, Welling K, Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1990:366:149-54.[Source: PubMed®]
     [Links: PMID: 2403004]
208. [Growth hormone treatment of short stature benefits the child from the psychological point of view].
     Albertsson-Wikland K, Ritzén M.
     Lakartidningen 1990:87(17):1495-9.[Source: PubMed®]
     [Links: PMID: 2338858]
209. Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies.
     Johansson G, Sietnieks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckx M, Holmberg C, Sipilä I, Broyer M, Rappaport R, Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1990:370:36-42; discussion 43.[Source: PubMed®]
     [Links: PMID: 2260456]
210. Birth data for patients who later develop growth hormone deficiency: preliminary analysis of a national register. The Executive Scientific Committee of the Kabi International Growth Study and the Swedish Paediatric Study Group for Growth Hormone Treatment.
     Albertsson-Wikland K, Niklasson A, Karlberg P.
     Acta Paediatr Scand Suppl 1990:370:115-20; discussion 1.[Source: PubMed®]
     [Links: PMID: 2260449]
211. Change in electrophoretic mobility of human follicle-stimulating hormone in serum after administration of gonadotropin-releasing hormone.
     Wide L, Albertsson-Wikland K.
     J Clin Endocrinol Metab. 1990:70(1):271-6.[Source: PubMed®]
     [Links: PMID: 2104625]
212. Bioequivalence of Genotropin1 16 IU/ml and 4 IU/ml.
     Albertsson-wikland Kerstin, Pettersson AS, Cleason Y, Danielson K, Guilbaud O, Widlund L.
     Acta Paediatr Scand 1990:370:183-183.[Source: User]
213. Improved growth response to GH treatment in irradiated children.
     Lannering B, Albertsson-Wikland K.
     Acta Paediatr Scand 1989:78(4):562-7.[Source: PubMed®]
     [Links: PMID: 2782071]
214. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Swedish Paediatric Study Group for Growth Hormone Treatment.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1989:349:35-41; discussion 53.[Source: PubMed®]
     [Links: PMID: 2750530]
215. Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles.
     Albertsson-Wikland K, Rosberg S, Libre E, Lundberg L O, Groth T.
     Am J Physiol. 1989:257(6):E809-14.[Source: PubMed®]
     [Links: PMID: 2610253]
216. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children.
     Gelander L, Albertsson-Wikland K.
     J Endocrinol. 1989:122(1):61-8.[Source: PubMed®]
     [Links: PMID: 2549156]
217. Effects of acute intravenous injection of two growth hormone-releasing hormones (GHRH 1-40 and 1-29) on serum growth hormone and other pituitary hormones in short children with pulsatile growth hormone secretion.
     Gelander L, Lindstedt G, Selstam G, Wide L, Albertsson-Wikland K.
     Horm Res. 1989:31(5-6):213-20.[Source: PubMed®]
     [Links: PMID: 2515143]
218. Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia.
     Moëll C, Garwicz S, Westgren U, Wiebe T, Albertsson-Wikland K.
     Arch Dis Child. 1989:64(2):252-8.[Source: PubMed®]
     [Links: PMID: 2494952]
219. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
     Edén S, Bengtsson B A, Albertsson-Wikland K, Elfversson J, Lindstedt G, Lundberg P A, Petruson B, Rosberg S.
     Acta Endocrinol. 1989:120(1):113-20.[Source: PubMed®]
     [Links: PMID: 2492135]
220. Growth hormone treatment of short stature. State-of-the-art 1989.
     Albertsson-Wikland K, Bischofberger E, Brook C G, Dahlström G, Edén S, Hall K, Kaplan S, Preece M, Ranke M B, Rappaport R.
     Acta Paediatr Scand Suppl 1989:362:9-13.[Source: PubMed®]
     [Links: PMID: 2485605]
221. Analyses of 24-hour growth hormone profiles in children: relation to growth.
     Albertsson-Wikland K, Rosberg S.
     J Clin Endocrinol Metab. 1988:67(3):493-500.[Source: PubMed®]
     [Links: PMID: 3410935]
222. Twenty-four-hour growth hormone profiles in pubertal girls with idiopathic scoliosis.
     Ahl T, Albertsson-Wikland K, Kalén R.
     Spine 1988:13(2):139-42.[Source: PubMed®]
     [Links: PMID: 3406831]
223. Infancy growth pattern related to growth hormone deficiency.
     Karlberg J, Albertsson-Wikland K.
     Acta Paediatr Scand 1988:77(3):385-91.[Source: PubMed®]
     [Links: PMID: 3389131]
224. Recombinant somatropin in treatment of growth hormone deficient children in Sweden and Finland.
     Albertsson-Wikland K, Aronson S, Nilsson K O, Ritzén M, Tuvemo T, Westgren U, Westphal O, Perheentupa J, Sipilä I, Wilton P.
     Acta Paediatr Scand Suppl 1988:347:176-9.[Source: PubMed®]
     [Links: PMID: 3254032]
225. Blunted pubertal growth after leukemia: a new pattern of growth hormone insufficiency.
     Moëll C, Garwicz S, Westgren U, Wiebe T, Albertsson-Wikland K.
     Horm Res. 1988:30(2):68-71.[Source: PubMed®]
     [Links: PMID: 3248779]
226. Growth hormone treatment in short children--short-term and long-term effects on growth.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1988:343:77-84.[Source: PubMed®]
     [Links: PMID: 3195335]
227. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour.
     Lannering Birgitta, Albertsson-Wikland Kerstin, Marky I, Mellander L.
     Acta Paediatr Scand Suppl 1988:343:146-51.[Source: PubMed®]
     [Links: PMID: 3143223]
228. Simplified growth hormone therapy--first clinical experience with the KabiPen.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1988:343:103-6.[Source: PubMed®]
     [Links: PMID: 3057801]
229. Infantile autism, fragile (X) (q27.3) and RFLP analysis in an extended Swedish family.
     Anvret M, Gillberg C, Wahlström J, Albertsson-Wikland K, Davies K.
     Clin Genet. 1988:34(4):265-71.[Source: PubMed®]
     [Links: PMID: 2906823]
230. Increased availability of human growth hormone. A challenge for health economics.
     Albertsson-Wikland K, Larsson A.
     Int J Technol Assess Health Care 1988:4(4):629-33.[Source: PubMed®]
     [Links: PMID: 10303062]
231. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels.
     Albertsson-Wikland K, Hall K.
     J Clin Endocrinol Metab. 1987:65(4):671-8.[Source: PubMed®]
     [Links: PMID: 3654912]
232. The effect of human growth hormone injection frequency on linear growth rate.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1987:337:110-6.[Source: PubMed®]
     [Links: PMID: 3481175]
233. A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors.
     Albertsson-Wikland Kerstin, Lannering Birgitta, Marky Ildiko, Mellander Lotta, Wannholt U.
     Acta Paediatr Scand 1987:76(6):966-73.[Source: PubMed®]
     [Links: PMID: 3425315]
234. Clinical trial with authentic recombinant somatropin in Sweden and Finland.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1987:331:28-34.[Source: PubMed®]
     [Links: PMID: 3300153]
235. Growth hormone release in children after cranial irradiation.
     Lannering B, Albertsson-Wikland K.
     Horm Res. 1987:27(1):13-22.[Source: PubMed®]
     [Links: PMID: 3114116]
236. Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).
     Gillberg C, Wahlström J, Johansson R, Törnblom M, Albertsson-Wikland K.
     Dev Med Child Neurol 1986:28(5):624-7.[Source: PubMed®]
     [Links: PMID: 3536640]
237. Daily subcutaneous administration of human growth hormone in growth hormone deficient children.
     Albertsson-Wikland K, Westphal O, Westgren U.
     Acta Paediatr Scand 1986:75(1):89-97.[Source: PubMed®]
     [Links: PMID: 3513479]
238. Growth hormone treatment in short children.
     Albertsson-Wikland K.
     Acta Paediatr Scand Suppl 1986:325:64-70.[Source: PubMed®]
     [Links: PMID: 3296640]
239. Carnitine in maternal and neonatal plasma.
     Cederblad G, Niklasson A, Rydgren B, Albertsson-Wikland K, Olegård R.
     Acta Paediatr Scand 1985:74(4):500-4.[Source: PubMed®]
     [Links: PMID: 4024920]
240. Disturbed GRF and GH secretion in brain irradiated children.
     Albertsson-Wikland Kerstin, Lannering B, Marky I, Mellander L, Vannholt U.
     The Endocrine Society 1985:1356:339-339.[Source: User]
241. How to predict the growth outcome of Growth Hormone treatment in short children?
     Albertsson-Wikland Kerstin, Westphal O, Hall K, Lindstedt G.
     Pediatric Research 1985:19(6):607-607.[Source: User]
242. GRF, tillväxthormon och somatomediner, aktuella tillväxtfaktorer av betydelse för longitudinell tillväxt.
     Westphal O, Albertsson-Wikland Kerstin, Fryklund L, Celander L, Hall K, Isaksson O.
     Acta Soc Med Suec Symposie 1984:93(2):275-275.[Source: User]
243. Recombinant DNA-teknik vid försök att identifiera fragil X i en familj med infantil autism.
     Anvret M, Gillberg C, Johansson IM, Wahlström J, Wikland Kerstin.
     Acta Soc Med Suec 1984:93(2):194-194.[Source: User]
244. Relationship between the biological and immunological activities of growth hormone circulating in normal rats.
     Lindahl A, Edén S, Albertsson-Wikland K, Isaksson O, Kostyo J L.
     Endocrinology 1983:112(6):2054-8.[Source: PubMed®]
     [Links: PMID: 6343058]
245. Inhibition of adenylate cyclase activity in muscles by growth hormone.
     Albertsson-Wikland K, Rosberg S.
     Endocrinology 1982:111(6):1855-61.[Source: PubMed®]
     [Links: PMID: 7140636]
246. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.
     Jansson J O, Albertsson-Wikland K, Edén S, Thorngren K G, Isaksson O.
     Acta Physiol Scand. 1982:114(2):261-5.[Source: PubMed®]
     [Links: PMID: 7136757]
247. Circumstantial evidence for a role of the secretory pattern of growth hormone in control of body growth.
     Jansson J O, Albertsson-Wikland K, Edén S, Thorngren K G, Isaksson O.
     Acta Endocrinol. 1982:99(1):24-30.[Source: PubMed®]
     [Links: PMID: 7058675]
248. Analysis of refractoriness to the effects of growth hormone on amino acid transport and protein synthesis in diaphragms of young normal rats.
     Albertsson-Wikland K, Edén S, Ahrén K, Isaksson O.
     Endocrinology 1980:106(1):298-305.[Source: PubMed®]
     [Links: PMID: 7349960]
249. Analysis of early responses to growth hormone on amino acid transport and protein synthesis in diaphragms of young normal rats.
     Albertsson-Wilkland K, Edén S, Isaksson O.
     Endocrinology 1980:106(1):291-7.[Source: PubMed®]
     [Links: PMID: 7349959]
250. In vitro effects of growth hormone on protein synthesis and amino acid transport in the rat diaphragm after acute hypophysectomy.
     Albertsson-Wirkland K, Edén S, Isaksson O.
     Acta Physiol Scand. 1979:105(2):215-21.[Source: PubMed®]
     [Links: PMID: 420020]
251. Time course of the effect of growth hormone in vitro on amino acid and monosaccharide transport and on protein synthesis in diaphragm of young normal rats.
     Albertsson-Wikland K, Isaksson O.
     Endocrinology 1978:102(5):1445-51.[Source: PubMed®]
     [Links: PMID: 744032]
252. Plasma levels of growth hormone in female rats of different ages.
     Edén S, Albertsson-Wikland K, Isaksson O.
     Acta Endocrinol. 1978:88(4):676-90.[Source: PubMed®]
     [Links: PMID: 581110]
253. Effect of insulin and adrenaline on cyclic AMP in the diaphragm of normal and diabetic rats.
     Edén S, Albertsson-Wikland K, Rosberg S, Isaksson O.
     Acta Endocrinol. 1977:85(4):806-17.[Source: PubMed®]
     [Links: PMID: 196469]
254. Development of responsiveness of young normal rats to growth hormone.
     Albertsson-Wikland K, Isaksson O.
     Metab Clin Exp. 1976:25(7):747-59.[Source: PubMed®]
     [Links: PMID: 940470]

Book (1)

1. Tillväxtkurvan i skolhälsovården. Tillväxt och kroppslig mognad 6-18 år. Manual och Lilla tillväxtskolan.
   Gelander L, Hagenäs L, Albertsson-Wikland Kerstin.
   Stockholm: Kommentus; 2003. ISBN ISBN 91-7345-137-1. [Source: User]

Book Chapter (36)

1. Child Growth as Outcome in Clinical Trials.
   Karlberg J, Albertsson-Wikland Kerstin.
   Textbook of Clinical Trials. Chichester, UK: John Wiley & Sons, Ltd; 2007, [Source: User]
2. Short- and Long-Term Response to Growth Hormone in Idiopathic Short Stature: KIGS Analysis of Factors Predicting Growth.
   Ranke B, Lindberg A, Price DA, Darendelier F, Albertsson-Wikland Kerstin, Wilton P, Reiter EO.
   Growth Hormone Therapy in Pediatrics - 20 Years of KIGS.. Basel, Switzerland: Karger; 2007, pp 319-25. ISBN 978-3-8055-8256-8. [Source: User]
3. Delayed Infancy-Childhood Growth Spurt (DICS) in ISS children.
   Kriström B, Hochberg Z, Albertsson Wikland Kerstin.
   46th annual meeting of the European Society for Paediatric Endocrinology (ESPE) Helsinki, Finland June 27-30, 2007. Basel, Switzerland: Karger; 2007, [Source: User]
4. Tillväxtrubbningar, pubertet och dess avvikelser.
   Gelander Lars, Albertsson Wikland K.
   Barnmedicin. Lund: Studentlitteratur; 2006, ISBN 91-44-04469-0. [Source: User]
5. Psychological Importance to the Child of Growth Hormone Replacement.
   Chaplin J, Dahlgren Jovanna, Kriström B, Albertsson-Wikland Kerstin.
   The Somatotrophic Axis in Brain Function. Amsterdam, Netherlands: Elsevier; 2006, pp 249-66. [Source: User]
6. Growth hormone replacement in GHD-children - effects on metal health (motivation, attention, and perception).
   Chaplin John, Kriström Berit, Dahlgren Jovanna, Albertsson Wikland Kerstin.
   The Somatotrophic Axis in Brain Function. New York: Elsevier, Science & Technology; 2006, [Source: User]
7. Turner's syndrome.
   Janson PO, Barrenäs ML, Landin-Wilhelmsen K, Albertsson-Wikland K.
   Paediatric and Adolescent Gynaecology A multidisciplinary approach. Cambridge: Cambridge University Press; 2004, pp 242-52. [Source: User]
   [Links: Google books]
8. The role of the gynecologist in the multidisciplinary management of girls and woman with Turner syndrome.
   Jansson P-O, Barrenäs M-L, Kriström B, Hansson C, Möller A, Wilhelmsen-Landin Kerstin, Albertsson-Wikland Kerstin.
   The multidisciplinary approach to the management of paediatric and adolescent gynaecology.. Cambridge, UK: Cambridge University Press; 2004, pp 242-52. [Source: User]
9. Turner syndrome management and research in a life-span prospective.
   Bryman I, Barrenäs M-L, Landin Wilhemlson K, Wide Boman U, Kriström B, Albertsson Wikland K.
   European practice in Gynaecology and Obstetrics Paediatric and adolescent gynaecology. Amsterdam: Elsevier; 2003, pp 181-90. ISBN 978-0-444-51360-1. [Source: User]
10. Methods of Evaluating Spontaneous Growth Hormone Secretion.
    Albertsson-Wikland Kerstin, Rosberg S.
    Functional Endocrinologic Diagnostics in Children and Adolescents. Mannheim, Germany: J & J Verlag; 2003, pp 129-59. [Source: User]
11. Turner Syndrome: Management and research in a life-span perspective.
    Bryman Inger, Barrenäs M-L, Landin-Wilhelmsen K, Wide Boman U, Kriström B, Albertsson-Wikland K.
    Paediatric and Adolescent Gynaecology. Amsterdam, Netherlands: Elsevier Health Sciences; 2003, pp 181-90. ISBN 9780444513601. [Source: User]
12. Tillväxtrubbningar, pubertet och dess avvikelser.
    Gelander L, Hagenäs L, Albertsson-Wikland Kerstin.
    Barnmedicin. Lund: Studentlitteratur; 2002, pp 185-207. [Source: User]
13. Quality of Life in Children and Adults with Growth Hormone Deficiency.
    Wiklund IK, Erling AE, Albertsson-Wikland Kerstin.
    Therapeutic Outcome of Endocrine Disorders.. New York, USA: Springer-Verlag; 2000, pp 21-9. [Source: User]
14. Turner Syndrome: Psychological Functioning Rated by Parents and by the Girls Themselves.
    Wide Boman U, Albertsson-Wikland Kerstin, Möller A.
    Therapeutic Outcome of Endocrine Disorders. New York, USA: Springer-Verlag; 2000, pp 131-6. [Source: User]
15. Timing of oestrogen therapy in girls with Turner syndrome: the Swedish experiences and a review.
    Nilsson K-O, Albertsson-Wikland Kerstin, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Kriström B, Marcus C, Moell C, Ritzén M, Tuvemo T, Westgren U, Westphal O, Åman J.
    Otimizing Health Care for Turner Patients in the 21st Century. Amsterdam, The Netherlands: Elsevier; 2000, pp 185-97. [Source: User]
16. Turner syndrome: psychological functioning rated by parents and the girls themselves.
    Wide Boman Ulla, Albertsson Wikland Kerstin, Möller Anders.
    Therapeutic outcome of endocrine disorders. New York: Springer; 2000, pp 131-136. [Source: User]
17. Boys with testicular volume 3 ml exhibit increased nocturnal testosterone levels.
    Ankarberg C, Albertsson-Wikland Kerstin, Norjavaara E.
    The onset of puberty in perspective : proceedings of the 5th International conference on the control of the onset of puberty, held in Liège, Belgium, 26-28th September 1999. Amsterdam,The Netherlands: Elsevier; 2000, ISBN 0-444-50296-3. [Source: User]
18. Leptin levels differs between the sexes during puberty.
    Ankarberg C, Dahlgren J, Albertsson-Wikland Kerstin, Norjavaara E.
    The onset of puberty in perspective : proceedings of the 5th International conference on the control of the onset of puberty, held in Liege, Belgium, 26-28th September 1999. Amsterdam,The Netherlands: Elsevier; 2000, ISBN 0-444-50296-3. [Source: User]
19. Tillväxtrubbningar, pubertet och dess avvikelser.
    Gelander Lars, Albertsson Wikland K.
    Barnmedicin. Lund: Studentlitteratur; 1999, ISBN 91-44-00980-1. [Source: User]
20. Septo-optic dysplasia: Experience with 151 cases in KIGS.
    Hellström A, Chatelain P, Cutfield W, Jönsson P, Price DA, Wilton P, Albertsson-Wikland Kerstin.
    Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg, Germany: J A Barth Verlag; 1999, pp 147-58. [Source: User]
21. Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS.
    Cutfield WS, Lindberg A, Chatelain P, Price DA, Albertsson-Wikland Kerstin, Wilton P, Ranke M.
    Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg, Germany: J A Barth Verlag; 1999, pp 93-110. [Source: User]
22. Turner syndrome: Demography, auxology and growth during growth hormone therapy in KIGS.
    Ranke MB, Lindberg A, Chatelain P, Cutfield W, Albertsson-Wikland Kerstin, Wilton P, Price DA.
    Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg, Germany: J A Barth Verlag; 1999, pp 245-58. [Source: User]
23. Development of the KIGS model for predicting the growth response to growth hormone replacement therapy in children with idiopathic growth hormone deficiency from start of treatment until final height.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland Kerstin, Price DA.
    Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg, Germany: J A Barth Verlag; 1999, pp 371-84. [Source: User]
24. Leptin levels differ between the sexes during puberty.
    Ankarberg C, Dahlgren Jovanna, Carlsson B, Albertsson-Wikland Kerstin, Norjavaara E.
    The Onset of Puberty in Perspective: Proceedings of the 5th International Conference on the Control of the Onset of Puberty. Amsterdam, Netherlands: Elsevier; 1999, ISBN 0-444-50296-3. [Source: User]
25. Critical review of measurement issues in quality of life assessment for children with growth problems.
    Wiklund I, Erling A, Albertsson-Wikland Kerstin.
    Measuring Health-Related Quality of Life in Children and Adolescents Implications for Reserch and Practice.. Erlbaum Associates Inc; 1998, pp 255-71. [Source: User]
26. Measuring health-related well-being in children, particularly in those of short stature.
    Erling A, Wikland I, Wirén L, Albertsson-Wikland Kerstin.
    Growth and Psyche. Hogrefc o Publishers; 1998, pp 255-71. [Source: User]
27. Methods of Evaluating Spontaneous Growth Hormone Secretion.
    Albertsson-Wikland Kerstin, Rosberg S.
    Functional Endocrinologic Diagnostics in Children and Adolescents. Mannheim, Germany: J & J Verlag; 1996, pp 149-75. [Source: User]
28. Clinical relevance of growth hormone measurements.
    Albertsson-Wikland Kerstin.
    Recent Advances on Growth and Growth Hormone Therapy. London, England: Freund Publishing House Ltd; 1996, pp 43-54. [Source: User]
29. Nutrition and linear growth in childhood.
    Karlberg J, Albertsson-Wikland Kerstin.
    Recent Developments in Infant Nutrition. London, England: Kluwer Academic; 1996, pp 112-27. [Source: User]
30. Physiological GH Secretion Changes with Age, Stature and Puberty.
    Albertsson-Wikland Kerstin, Rosberg S.
    Frontiers of Paediatric Neuroendocrinology.. Oxford, England: Blackwell Scientific Publications Ltd; 1994, pp 131-7. [Source: User]
31. Methods of Evaluating Spontaneous Growth Hormone Secretion.
    Albertsson-Wikland Kerstin, Rosberg S.
    Functional Endocrinologic Diagnostics in Children and Adolescents. Mannheim, Germany: J & J Verlag; 1992, pp 76-101. [Source: User]
32. Nasal administration of human growth hormone and calcitonin.
    Hedin L, Rosberg S, Albertsson-Wikland Kerstin, Bengtsson P.
    Buccal and Nasal Administration of Drugs as an Alternative to Parenteral Administration. Paris, France: Editions de Sante[entity]769;; 1992, pp 238-45. [Source: User]
33. Pattern of growth hormone secretion in children.
    Albertsson-wikland Kerstin, Rosberg S.
    Abstracts / 2nd International Congress of Neuroendocrinology. Basel: Karger; 1990, pp 22-3. ISBN 3-8055-5252-1. [Source: User]
34. Dynamics of Growth Hormone Secretion in Girls with Turner Syndrome.
    Albertsson-Wikland Kerstin, Rosberg S.
    Turner Syndrome.. New York, New York, USA: Marcel Dekker Inc; 1989, pp 233-46. [Source: User]
35. Hypoglycemia in normal infants delivered by caesarean section.
    Niklasson A, Albertsson-Wikland Kerstin, Rydgren B, Olegård R.
    VIIIth [eighth] European Congress of Perinatal Medicine: Brussels, 7 -10 September, 1982. Elsevier; 1982, [Source: User]
36. Growth hormone and somatic growth.
    Isaksson O, Eden S, Albertsson-Wikland Kerstin.
    Endocrinology 1980 : proceedings of the VI International Congress of Endocrinology, Melbourne, Australia, February 10-16, 1980. Amsterdam: Elviser; 1980, pp 206-9. ISBN 0858470624. [Source: User]

Conference Paper - Peer reviewed (141)

1. Signal transduction in child health: closing the gap between clinical and basic research.
   Chan Li, Albertsson-Wikland Kerstin, Camacho-Hübner Cecilia, Hochberg Ze'ev.
   2010. [Source: PubMed®]
   [Links: PMID: 20940424 | DOI länk]
2. Protein markers of body composition in response to growth hormone (GH) treatment in short prepubertal children.
   Decker Ralph, Andersson Björn, Nierop Andreas, Bosaeus Ingvar, Dahlgren Jovanna, Hellgren Gunnel, Albertsson-Wikland Kerstin.
   Varberg: The 2010 New Inroads to Child Health Conference on Child Health and Signal Transduction; 2010. [Source: User]
3. Protein expression profiling supports “the biphasic model” theory of bone mineralization in response to growth hormone treatment in short prepubertal children.
   Hellgren G, Andersson B, Decker R, Nierop AFM, Bosaeus I, Albertsson Wikland Kerstin.
   Varberg, Sweden: The 2010 New Inroads to Child Health Conference on Child Health and Signal Transduction; 2010. [Source: User]
4. GH dosing guided by individual responsiveness decreases variability in growth response and insulin in GHD and ISS children.
   Kriström B, Decker R, Dahlgren J, Gustafsson J, Hochberg Z, Albertsson-Wikland Kerstin.
   Varberg, Sweden: The 2010 New Inroads to Child Health Conference on Child Health and Signal Transduction; 2010. [Source: User]
5. Metabolic outcome of GH treatment in prepubertal children with idopathic short stature compared with GH-deficient children.
   Dahlgren J, Decker R, Albertsson-Wikland Kerstin, Kriström B, Gustafsson J, Hochberg Z.
   San Diego, California, USA: ENDO 2010; 2010. [Source: User]
6. Protein profiling identified dissociations between growth hormone-mediated longitudinal growth and bone mineralization in prepubertal children.
   Hellgren G, Andersson B, Decker R, Nierop AFM, Bosaeus I, Albertsson-Wikland Kerstin.
   Gothenburg, Sweden: Medicinska Riksstämman. Dec 1-3; 2010. [Source: User]
7. Serum protein profiles correlate with bone mineralization during growth hormone (GH) treatment in short prepubertal children.
   Hellgren G, Andersson B, Nierop AFM, Hochberg Z, Albertsson.Wikland Kerstin.
   Stockholm, Sweden: European Proteomics Association Congress in Clinical Proteomics; 2009. [Source: User]
8. Growth hormone treatment improves quality of life in ideopathic short stature and not in growth hormone deficient children.
   Chaplin J, Albetsson-Wikland Kerstin, Dahlgren J, Hägglöf B, Tuvemo T, Jonsson B, Kriström B.
   New Orleans, Louisiana, USA: 2009 International Society for Quality of Life Research Annual Conference; 2009. [Source: User]
9. Children with Delayed Infancy Childhood Transition (DICT) respond better to GH treatment compared to Non-DICT children; results from a randomized, controlled clinical trial.
   Albertsson-Wikland Kerstin, Kriström B, Dahlgren J, Jonsson B, Hochberg Z.
   Istanbul, Turkey: European Society for Paediatric Endocrinology; 2008. [Source: User]
10. The GH/IGF-I axis in children with Noonan Syndrome compared to girls with Turners syndrome.
    Dahlgren J, Deborah O, Westphal P, Albertsson-Wikland Kerstin.
    Istanbul, Turkey: European Society for Paediatric Endocrinology; 2008. [Source: User]
11. Identification of nutritional factors in serum descriminationg between high and low GH responders.
    Andersson B, Hellgren G, Nierop AFM, Hochberg Z, Albertsson-Wikland Kerstin.
    Istanbul, Turkey: European Society for Paediatric Endocrinology; 2008. [Source: User]
12. Serum estradiol levels and growth velocity in healty girls.
    Norjavaara E, Ankarberg-Lindgren C, Niklasson A, Westgren U, Albertsson Wikland Kerstin, Albin AK.
    Toronto, USA: ENDO, June 2-5; 2007. [Source: User]
13. Serum estradiol levels and growth velocity in healthy girls.
    Albin AK, Ankarberg-Lindgren C, Niklasson A, Westgren U, Albertsson Wikland Kerstin, Norjavaara E.
    Helsinki, Finland: European Society for Paediatric Endocrinology (ESPE). June 27-30; 2007. [Source: User]
14. Identification of novel GH and IGF-I responsive genes in cartilage by microarray.
    Kim HS, Olsson B, Swolin D, Lindahl A, Carlsson B, Albertsson-Wikland Kerstin, Bjarnsson R, Carlsson L.
    Boston, USA: GRS, Sept 2002; 2007. [Source: User]
15. Cardiac expression of growth hormone (GH) receptor and insulin-like growth factor-I (IGF-I) mRNA in congenital heart disease.
    Nygren Anders, Sunnegårdh Jan, Albertsson-Wikland Kerstin, Berggren Håkan, Isgaard Jörgen.
    Aarhus, Denmark: 36th Nordic Paediatric Cardiology Meeting; 2006. [Source: User]
16. Secular changes in overweight and obesity among 10-year old children in Göteborg.
    Sjöberg A, Lissner L, Albertsson-Wikland Kerstin, Mårild S.
    Reykjavik, Island: Nordic Obesity Meeting; 2006. [Source: User]
17. Improved assessment of bone status in children with the Lunar pediatric total body software.
    Fors H,